Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases

  1. Lilienfeld-Toal, Marie von
  2. Vehreschild, Jörg ORCID logo
  3. Cornely, Oliver ORCID logo
  4. Pagano, Livio
  5. Compagno, Francesca
  6. Pagliuca, Antonio
  7. Akan, Hamdi
  8. Lagrou, Katrin
  9. Hoenigl, Martin
  10. Klimko, Nikolai
  11. Verweij, Paul
  12. Duarte, Rafael
  13. Zimmerli, Stefan
  14. Bretagne, Stephane
  15. Racil, Zdenek
  16. Hirsch, Hans H.
  17. EHA Infectious Disease Scientific Working Group

Download
s41375-020-0832-y.pdf 883,75KB
WeightNameValue
1000 Titel
  • Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases
1000 Autor/in
  1. Lilienfeld-Toal, Marie von |
  2. Vehreschild, Jörg |
  3. Cornely, Oliver |
  4. Pagano, Livio |
  5. Compagno, Francesca |
  6. Pagliuca, Antonio |
  7. Akan, Hamdi |
  8. Lagrou, Katrin |
  9. Hoenigl, Martin |
  10. Klimko, Nikolai |
  11. Verweij, Paul |
  12. Duarte, Rafael |
  13. Zimmerli, Stefan |
  14. Bretagne, Stephane |
  15. Racil, Zdenek |
  16. Hirsch, Hans H. |
1000 Mitwirkende/r
  1. EHA Infectious Disease Scientific Working Group |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-05-01
1000 Erschienen in
1000 Quellenangabe
  • 34:1487-1494
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1038/s41375-020-0832-y |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194246/ |
1000 Interne Referenz
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Since early 2020, the SARS-CoV-2 pandemic has a massive impact on health care systems worldwide. Patients with malignant diseases are assumed to be at increased risk for a worse outcome of SARS-CoV-2 infection, and therefore, guidance regarding prevention and management of the infection as well as safe administration of cancer-therapy is required. Here, we provide recommendations for the management of patients with malignant disease in the times of COVID-19. These recommendations were prepared by an international panel of experts and then consented by the EHA Scientific Working Group on Infection in Hematology. The primary aim is to enable clinicians to provide optimal cancer care as safely as possible, since the most important protection for patients with malignant disease is the best-possible control of the underlying disease.
1000 Sacherschließung
gnd 1206347392 COVID-19
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://d-nb.info/gnd/121251268|https://orcid.org/0000-0002-5446-7170|https://orcid.org/0000-0001-9599-3137|https://frl.publisso.de/adhoc/uri/UGFnYW5vLCBMaXZpbw==|https://frl.publisso.de/adhoc/uri/Q29tcGFnbm8sIEZyYW5jZXNjYQ==|https://frl.publisso.de/adhoc/uri/UGFnbGl1Y2EsIEFudG9uaW8=|https://frl.publisso.de/adhoc/uri/QWthbiwgSGFtZGk=|https://frl.publisso.de/adhoc/uri/TGFncm91LCBLYXRyaW4=|https://frl.publisso.de/adhoc/uri/SG9lbmlnbCwgTWFydGlu|https://frl.publisso.de/adhoc/uri/S2xpbWtvLCBOaWtvbGFp|https://frl.publisso.de/adhoc/uri/VmVyd2VpaiwgUGF1bA==|https://frl.publisso.de/adhoc/uri/RHVhcnRlLCBSYWZhZWw=|https://frl.publisso.de/adhoc/uri/WmltbWVybGksIFN0ZWZhbg==|https://frl.publisso.de/adhoc/uri/QnJldGFnbmUsIFN0ZXBoYW5l|https://frl.publisso.de/adhoc/uri/UmFjaWwsIFpkZW5law==|https://frl.publisso.de/adhoc/uri/SGlyc2NoLCBIYW5zIEgu|https://frl.publisso.de/adhoc/uri/RUhBIEluZmVjdGlvdXMgRGlzZWFzZSBTY2llbnRpZmljIFdvcmtpbmcgR3JvdXA=
1000 Label
1000 Förderer
  1. Springer Nature |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. Open access funding by Projekt DEAL
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Springer Nature |
    1000 Förderprogramm Open access funding by Projekt DEAL
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6422048.rdf
1000 Erstellt am 2020-07-21T15:00:10.556+0200
1000 Erstellt von 25
1000 beschreibt frl:6422048
1000 Bearbeitet von 25
1000 Zuletzt bearbeitet Tue Jul 21 15:01:50 CEST 2020
1000 Objekt bearb. Tue Jul 21 15:01:33 CEST 2020
1000 Vgl. frl:6422048
1000 Oai Id
  1. oai:frl.publisso.de:frl:6422048 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source